VGHCX Vanguard Health Care Inv Forecast, Technical & Fundamental Analysis

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Unitedhealth Group (NYSE:UNH), AstraZeneca PLC (NYSE:AZN), Intuitive Surgical (NASDAQ:ISRG), CVS HEALTH Corp (NYSE:CVS), Edwards Lifesciences Corp (NYSE:EW).

The investment seeks long-term capital appreciation. Under normal circumstances, the fund invests at least 80% of its net assets, plus the amount of any borrowings for investment purposes, in the stocks of companies principally engaged in the development, production, or distribution of products and services related to the health care industry. The adviser may also consider companies engaged in medical, diagnostic, biochemical, and other research and development activities. The fund may invest up to 50% of its assets in foreign stocks. It is non-diversified.

The average market capitalization across the Vanguard Health Care Inv MF is 274.82B. The market cap for tickers in the group ranges from 51.75B to 1.12T. LLY holds the highest valuation in this group at 1.12T. The lowest valued company is EW at 51.75B.

The average weekly volume growth across all stocks in the Vanguard Health Care Inv MF was 13%. For the same stocks of the MF, the average monthly volume growth was -20% and the average quarterly volume growth was -19%